CVSICV Sciences, Inc.

About CV Sciences, Inc. (CVSI)

CV Sciences, Inc. (CVSI) is a Drug Manufacturers - Specialty & Generic company headquartered in San Diego, CA, United States whose shares trade over-the-counter on the OTCQB tier.

CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company's hemp extracts and other proven, science-backed, natural ingredients and products are sold through a range of sales channels from B2B to B2C. The Company's +PlusCBD™ branded products are sold at select retail locations throughout the U.S. and are the top-selling brands of hemp extracts in the natural products market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. With a commitment to science, +PlusCBD™ product benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov. +PlusCBD™ was the first hemp extract supplement brand to invest in the scientific evidence necessary to receive self-affirmed Generally Recognized as Safe (GRAS) status. The Company's Cultured Foods™ brand provides a variety of 100% plant-based food products. Committed to crafting nutritious and flavorful alternatives, Cultured Foods™ caters to individuals seeking vegan, gluten-free, or flexitarian options for a wholesome and satisfying culinary experience. In addition, the Company owns Elevated Softgels, a leading manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry. CV Sciences has primary offices and facilities in San Diego, California, Grand Junction, Colorado, and Warsaw, Poland.

Products and services

We develop, manufacture, market and sell herbal supplements, CBD products and plant-based food products under the following brands: +PlusCBD™ and Cultured Foods™ in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. • +PlusCBD™ - Our award-winning line of products available in softgel, tinctures, topicals, and gummies. It was our first brand to market, released in 2014, and is the top-selling brand of hemp-derived CBD in the natural product retail market. +PlusCBD™ is backed by published research, third party safety testing, and rigorous quality standards. In addition, products under our +PlusCBD™ Pet brand offer all the hemp extract benefits offered by +PlusCBD™ for human use, but they are formulated just for cats and dogs. +PlusCBD™ Pet provides physical and emotional support to help address the stress and physical discomfort keeping pets from being their best. Available in easy to use liquids and flavors: beef, chicken, and peanut butter. • Cultured Foods™ - Products under our Cultured Foods™ brand are currently being distributed in Europe. Our products are entirely plant-based, natural, gluten-free and shelf-stable. We are also developing cannabinoids intended to treat medical indications. Our product candidate, CVSI-007, combines CBD and nicotine in treatment of smokeless tobacco use and addiction.

CVSI key facts

Ticker symbol

CVSI

Market tier

OTCQB

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

San Diego, CA, United States

Country of incorporation

US

Year of incorporation

2010

Employees

49

Estimated market cap

$5.87M (as of Apr 10, 2025)

Shares outstanding

184,793,663

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

CV Sciences, Inc. leadership

• Joseph Dowling — CEO, Secretary
• Joerg Grasser — CFO

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with C